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Abstract 
 
The auditory temporal processing deficits associated with age-dependent hearing decline 
have been increasingly attributed to issues beyond peripheral hearing loss. Age-related hearing 
loss (ARHL), also known as presbycusis, is linked with changes in the expression of both 
excitatory and inhibitory neurotransmitters in the central auditory system. There are also age-
related changes in the expression and function of the ion channels which mediate action potential 
firing. The slow, Ca2+ activated, K+ channels of the BK-type are essential in controlling both 
neurotransmitter release and neural communication via alteration of action potential durations, 
firing frequency, and neural adaptation. There are many subsets of this type of ion channel located 
throughout the body, and though it is evident that these channels are involved in cellular activation 
within the peripheral auditory system, little is known about their contribution to auditory 
processing in the brain. There is a need for further understanding of the functional involvement 
and mechanisms of neurotransmitter loss and how this relates to the BK channel and auditory 
disorders such as presbycusis and tinnitus (the perception of a phantom sound). My research 
focused on investigating how the downregulation of neurotransmitter production and the 
reductions in BK channel expression affect ARHL. I also evaluated a custom BK-channel 
modulating peptide as a path towards a possible therapeutic intervention for age-related hearing 
loss. This custom peptide is especially useful because it reduces the potential for serious side 
effects, due to mechanisms which best mimic natural occurring peptide systems.  
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The initial investigation described in this dissertation measured auditory system changes 
in aged mice that occurred following a drug-induced increase in the availability of the inhibitory 
neurotransmitter GABA. This increase in GABA decreased minimum response thresholds in the 
auditory midbrain of aged mice, bringing them to levels seen in young adult animals. The other 
changes that occurred following increased GABA availability were increased acoustically driven 
neuronal firing rates, frequency-dependent decreases in spontaneous rates, and increases in the 
symmetry of the receptive fields. The return of clear and fine-tuned acoustically-evoked responses 
in aged mice was a major finding of this experiment.  
The second phase of the dissertation built on this demonstration that modulation of the 
aged auditory system was possible by changing neurotransmitter levels. This second portion of the 
study focused on how a novel potent neuropeptide (LS3), which increases the probability of the 
BK channel remaining in the closed conformational state, might invoke alterations in auditory-
evoked responses. First, the LS3 neuropeptide was used to modify addictive behavior in the C. 
Elegans; followed by evaluation of in vitro changes to a human cell line. This study then confirmed 
that LS3 is a potent BK channel modulator with a greater affinity than those known toxins 
classified as high-affinity toxins. In vivo testing demonstrated that LS3 could rapidly cross the 
blood-brain barrier (BBB) following systemic injections, where it altered auditory evoked activity 
in a manner similar to that of the direct application to the dura over the midbrain. This work 
demonstrates that the BK channel is highly responsible for the control of auditory-evoked 
neurological processes, and that a potent BK channel modulator may be useful for the treatment 
of certain neurological disorders.  
The third study was designed to confirm that the BK channel plays an important role in 
sound-evoked activity generated in the auditory midbrain, by testing the effects of a general BK 
vi 
channel pore blocker, PAX. The results established that the BK channel is vital for sound 
processing in the midbrain of young adult mice, and is responsible for the maintenance of receptive 
field properties. I also evaluated the role it plays in temporal processing, which is an underlying 
mechanism for the processing of neurologically-relevant complex acoustic signals such as speech. 
Here, blocking of the channel increased (worsened) the threshold for the detection of a silent gap-
in-noise and the neural recovery functions that occurred following the stimuli. 
The fourth study significantly expanded the in vivo testing of the custom peptide channel 
blocker, LS3, and added a behavioral measure of changes to auditory perception in addition to the 
electrophysiology recordings. The auditory-evoked receptive fields from midbrain neurons were 
modulated in a dose-dependent manner following the application of LS3. The neural recordings 
took place in the inferior colliculus, where the dorsal region responds to low-frequency sounds and 
ventral areas to high frequencies. The LS3-induced suppression or enhancement of evoked 
responses was different for the various tonotopic regions of the auditory midbrain. The 
improvements shown in receptive fields and improvement in auditory perception indicates a 
plausible route for direct translational treatment of auditory disorders through small custom 
peptide therapeutics. These studies provide supportive information about how auditory evoked 
responses in the midbrain, including the coding of different sound features, are affected by the 
down-regulation of a key inhibitory neurotransmitter (GABA), and how GABA-dependent neural 
evoked responses are altered in older mice through the modulation of BK channel activity. 
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Chapter 1: Introduction 
 
Numerous mechanisms within the nervous system functionally decline as part of the 
normal aging process. These declines are multifaceted and are typically described as the loss of 
neurons and changes in neurochemistry concomitantly with degradation of their functional 
components (i.e. axons, dendrites, and synapses). Genetic, environmental, and age-linked changes 
in hormonal, cardiovascular, and metabolic functions also provide additional challenges [1-4]. The 
auditory system is no exception in its vulnerability to these and other biological aging changes, 
which ultimately leads to degradation in auditory perception, especially in difficult listening 
situations such as background noise or reverberation. This collection of maladies is known 
clinically as presbycusis, or age-related hearing loss (ARHL). The prevalence of this disorder 
ranges from over 30% for adults aged 65-75 years to over 50% for those individuals over 75 [5, 
6]. There are two components to ARHL, an increase in peripheral hearing thresholds (particularly 
for the high-frequencies) and central auditory processing deficits in spectral and temporal domains. 
These combined components result in difficulty understanding speech in noisy environments, 
impaired auditory localization, and declines in the processing of auditory information [5, 7-10]. 
Currently, there are no known interventions to prevent or treat sensorineural hearing loss, which 
occurs within the brain. 
The main symptom of ARHL is the diminished ability to understand rapid or degraded 
speech, as well as speech in noisy environments. These difficulties arise from declines in the ability 
to discriminate and extract timing, duration, and frequency cues of relevant acoustic informational 
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cues [10]. The central auditory components of ARHL are increasingly studied using functional 
imaging techniques, which can map the interconnections between brain nuclei. Many of these have 
found a disconnect between auditory regions [11] and their structural integrity [12], though the 
source of these breaks is still unknown. The inferior colliculus (IC) is a key auditory nucleus used 
in the study of the relationship between the declines in temporal processing and deficits in 
peripheral auditory sensitivity [13, 14]. Acoustic information is processed in the IC from 
independent pathways in both the ascending and descending directions (i.e. from multiple lower 
and higher order nuclei in the brain), as well as those between the cerebral hemispheres [15]. Due 
to the complex monaural and binaural processing taking place within the IC [16], studies 
examining the age-related changes in various types of auditory processing, for example, temporal 
and spectral perception have increased in recent years. The IC is of particular interest, in part 
because there is a large body of evidence that show age-related changes in neurochemistry, and 
neural processing occur within the IC. These studies include assessing how age affects neural 
responses when discriminating between different durations for noise and tonal stimuli [17, 18], 
when presented with frequency sweeps [19, 20], and during the detection of silent gaps in noise 
[21, 22]. They also indicate that studying the function of the IC over long periods of time may be 
useful in identifying key mechanisms in ARHL [10, 23]. Thusly, age-related changes in the IC 
will no doubt have an effect on auditory function due to the IC’s pivotal processing position in the 
central auditory nervous system, including the coding of complex sounds in quiet and background 
noise [24]. 
Caspary et al. discussed how research has indicated that both synaptic inhibition and post-
synaptic regulation within the IC are possible mechanisms for age-related declines in sound 
localization and temporal processing [23]. Indeed, there is evidence of an age-related 
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downregulation of neurotransmitters found in auditory nuclei throughout the brain [16, 25, 26]. 
This reduction in the expression of neurotransmitters, both excitatory and inhibitory, may underlie 
the functional declines of ARHL and the associated deficits in temporal processing [16, 23, 27, 
28]. Another age-related change is in the expression and functionality of voltage-gated ion 
channels, which regulate neural transmission through mediation of action potential timing, 
duration, and rates of adaptation [29-32]. 
The ability of the IC to process and transmit auditory information from the brainstem to 
ascending nuclei relies on unique neuronal discharge patterns, which are vulnerable to various 
insults [33]. Specifically, large-conductance voltage-gated and Ca+-activated K+ (BK) channels 
are important in mediating the transmission of acoustically relevant information via control of 
spike time and frequency [34-36]. Slice work from the IC of the rat found that blocking these 
potassium channels significantly altered the response patterns of neurons by abolishing sustained 
firing, lengthening onset spike latencies, and significantly altering spike durations [33]. BK 
channels are pivotal in the control of both the fast after-hyperpolarization and repolarization [34] 
following an action potential, which alters neural transmission properties. The BK channel is also 
highly involved in neurotransmitter release [37, 38], which as described above, is similarly 
important for auditory processing and understanding the neural bases of ARHL. BK channel 
expression levels vary throughout the central auditory system; expression levels begin to show 
high expression within the IC and higher order nuclei with very low to non-existent levels being 
found in auditory nuclei caudal to the IC [39]. 
Objectives of this dissertation include elucidating several of the neural components of 
ARHL, with a focus on the alteration of central auditory elements that facilitate synaptic 
transmission. In particular, it is anticipated that this research can then further assist in the 
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understanding of deficits in temporal processing. The rationale behind this work is that the 
mechanisms behind why the neurotransmission of relevant auditory information is diminished in 
aging and conditions such as hearing loss, dyslexia, and central auditory processing disorders must 
be understood before potential therapeutic interventions can be found and optimized. 
1.1 Research Contributions 
The research contributions contained within the Chapters and Appendixes C, D, and E are 
described here: 
1. The first study, contained in Appendix C, describes the effects of increasing the 
availability of the inhibitory neurotransmitter GABA, via systemic injection of 
vigabatrin (VGB), in the auditory midbrain of old mice. Increasing available GABA 
decreased minimum thresholds, altered receptive fields, and increased sound-evoked 
firing rates in aged animals. There were also frequency-dependent decreases in 
spontaneous rates and increases in the symmetry of the receptive fields following 
increased GABA availability. The highlight of this study is the return of clear and fine-
tuned receptive field profiles in aged animals, which resembled those seen in young 
adult animals, following the increases in available GABA. 
2. The study contained in Appendix D explains the development of a novel potent 
neuropeptide and its role as a targeted large conductance Ca2+-activated K+ channel 
(BK) channel modulator. We explored the modulation of some of the neural 
underpinnings of addictive behavior via a novel neuropeptide (LS3) that modulates BK 
channel activity in C. Elegans, along with the in vitro changes induced to a human cell 
line. This paper also investigates the alteration induced in auditory evoked potentials 
in vivo. In vitro application of LS3 using inside-out patch clamp demonstrates that it is 
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a potent BK channel modulator, with a greater affinity than those known toxins 
classified as high-affinity toxins to the BK channel. LS3 was also shown to rapidly 
cross the BBB following systemic injections where it altered auditory evoked activity 
in a manner similar to that of the direct application to the dura of the midbrain. This 
work demonstrates that the BK channel is highly responsible for the control of central 
auditory-evoked responses, and that a potent BK channel modulator may be useful for 
the treatment of neurological or sensory disorders. 
3. The study presented in Chapter 4 confirms that the BK channel plays an important role 
in sound-evoked activity generated in the inferior colliculus by using a general channel 
pore blocker. These experiments confirm that the BK channel affects sound processing 
in the midbrain of young adult animals, and show how it compares to the response 
properties of aged animals. Blocking the BK channel with Paxilline (PAX) directly 
affects maintenance of receptive field properties and modulates temporal processing 
through alterations in minimum gap detection thresholds and gap-in-noise recovery 
functions. Of note in this chapter is that blocking this ion channel results in the 
devolvement of response properties in young adult animals which resemble those seen 
in aged animals. 
4. The study contained in Appendix E contains data which significantly expands the work 
explored in the preceding section (Appendix D) with a focus on the translational 
possibilities using in vivo experiments. Here, I found that receptive fields were 
modulated in both a dose-dependent and tonotopic manner following the application of 
LS3. The improvements in both auditory-evoked midbrain receptive fields and 
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behavioral assessments indicates that there is a distinct possibility for small custom 
peptides to work as a treatment for auditory disorders. 
My work is anchored in using neurological-based biomedical engineering methods to 
develop a better understanding of functional declines in the brain and their relation to ARHL. In 
summary, the research presented in this dissertation provides new information about how auditory 
evoked responses in the midbrain, including the coding of different sound features, are affected by 
the down-regulation of a key neurotransmitter, GABA. There is also an analysis of the different 
components of auditory responses, how they are altered in older animals, and how they are affected 
by modulating the BK ion channel. The results presented provide a significant contribution to the 
knowledge base surrounding midbrain processing in ARHL and could facilitate the development 
of possible therapeutic treatments to prevent or reverse permanent hearing loss. 
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Chapter 2: Increasing GABA Reverses Age-Related Alteration in Excitatory Receptive 
Fields and Intensity Coding of Auditory Midbrain Neurons in Aged Mice 
 
Several studies have reported that the age-related changes in central auditory processing 
are partially due to alterations in neurotransmitter levels [16, 21, 40-44]. Sensory receptive fields 
(RFs) in the auditory system provide information on the thresholds and best response frequency 
of neurons, and are primarily formed by the interplay of excitation and inhibition in the auditory 
midbrain. The primary inhibitory neurotransmitter in the IC is γ-aminobutyric acid (GABA), and 
GABAergic inhibition is thought to sharpen these RFs. GABA receptors alter the signals from 
lower order nuclei (i.e. the brainstem) and change how the information is then transmitted to the 
thalamus. [33, 45]. The convergence of projections from various auditory nuclei in the IC plays a 
critical role in shaping neural responses to sound stimuli by removing noise and sharpening the 
processed auditory neural signals [46-49]. Several studies show that reductions in inhibitory 
neurotransmitter expression in the central auditory system may contribute to the diminished ability 
to process complex sound stimuli observed in ARHL [16, 23, 27, 43, 50, 51]. However, none of 
these studies explored the effects of altering GABA while recording evoked responses from the 
midbrain. This paper examines the direct relationship between the GABA and ARHL, through 
measurements of the evoked responses within the auditory midbrain following the upregulation of 
__________________ 
1This chapter article is under review for publication in Neurobiology of Aging (Brecht et. al. 
Increasing GABA reverses age-related declines in excitatory receptive fields and intensity coding 
of auditory midbrain neurons in mice. Neurobiol Aging, 2017.), and can be found in Appendix C.  
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GABA. This was carried out via systemic injection of VGB to block GABA transaminase. 
Increasing GABA availability altered minimum response thresholds in aged mice, essentially 
causing the affected neurons to respond to sound levels that were lower, and at the levels seen in 
young animals. This increased GABA availability also increased acoustically driven response 
rates, decreased spontaneous rates in a frequency dependent manner, and improved RF symmetry.   
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Chapter 3: A Novel BK Channel-Targeted Peptide Suppresses Sound-Evoked Activity in 
the Mouse Inferior Colliculus 
 
Voltage-gated channels of the potassium family mediate the outward flow of the K+ 
current, thus controlling the hyperpolarization of cells [35, 36]. BK channels are expressed 
throughout the body in both neurons and muscle, where they are responsible for modulation of 
cellular activity. Blocking the BK channel in vitro can significantly reduce the release of 
neurotransmitters [52], broaden the action potential [53, 54], eliminate the fast after-
hyperpolarization [34], and reduce firing frequency [55]. Studies have also implicated this voltage-
gated channel in spike frequency adaptation and the enhancement of neural discharge in many 
sensory neural systems [55, 56], which could alter information that is passed from lower order 
nuclei in the brainstem and midbrain to higher order nuclei in the cortex [20]. Years of research 
into the potential pharmaceutical application of altering BK channel function has been conducted 
in regards to treating several different neurological disorders [57, 58]. While there are several 
known peptides which can alter BK channel function, until recently [59], there were no 
pharmacologically relevant peptides that were amenable to large scale production and had both the 
ability to cross the BBB and a high selectivity for the BK channel [36, 60, 61]. A custom derived 
9-amino acid peptide, LS3, explored initially by Davis et al. [59] and described within this 
__________________ 
2The article, (Scott, L.L., et al., A novel BK channel-targeted peptide suppresses sound evoked 
activity in the mouse inferior colliculus. Sci Rep, 2017. 7: p. 424-33.), is published in Nature: 
Scientific Reports, and can be found in Appendix D.  
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manuscript, has a unique action, suppressing the gating of the BK channel rather than blocking the 
pore. This paper presents data which indicates that not only does the custom derived peptide, LS3, 
change the in vitro probability of both a nematode and a human cell culture derivate of the BK 
channel remaining in the open conformational state, but that it also modulates murine auditory 
evoked responses in vivo. The study first shows that LS3 can modulate the behavioral assay of 
alcohol intoxication and addictive behavior in nematodes. The application of LS3 to C. Elegans 
and human cell lines demonstrated that the peptide was a potent BK channel modulator with a 
greater affinity than other known high-affinity toxins. LS3 was also shown to quickly cross the 
BBB after systemic injection in the mouse, and altered sound-evoked activity in the auditory 
midbrain in a way which was similar in magnitude to that found following direct application to the 
dural surface of the mouse midbrain. The overall conclusion is that this potent peptide modulator 
of the BK channel may be useful for many neurological applications, such as treating 
hyperexcitability, convulsions, and seizures, as well as a possible therapeutic for ARHL.  
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Chapter 4: Neural Correlates of the BK Channel’s Role in Temporal Sound Processing 
Features Within the Inferior Colliculus 
 
In this research, I show that acoustically evoked neural responses can be altered by 
modulating the BK channel with a general K+ channel pore blocker, PAX. The use of a specific 
pore blocker confirms that the BK channel is critical in the neural coding of auditory information 
within the auditory midbrain, and generally in the auditory system (via both systemic and direct 
topical administration). The large alterations in sound-evoked driven firing within the midbrain 
give confirmation that modulating the main isoform of this ion channel can be beneficial, which 
led to further evaluation of LS3 and its family (LS10 LS4) in the study described in chapter 5. 
4.1 Introduction 
PAX, a fungal tremorgenic mycotoxin, is an indole alkaloid and a known producer of 
neurological disorders [62, 63]. While chemicals in these groups seldom cause death, they are 
known to disrupt motor activity and cause immobility, and these symptoms are often followed by 
convulsions or hyperexcitability [63]. The mechanisms by which these fungal toxins act is not well 
understood, but they are suspected to modulate the release of GABA and act as a negative allosteric 
modulator of the BK channel [63, 64]. Due to interactions with smooth muscles, PAX was initially 
investigated using patch clamp electrophysiology and compared to alternative blockers of the BK 
channel which had no real potential as therapeutic agents, such as scorpion toxins and 
tetraethylammonium [65], in arterial cell cultures and oocytes [66]. This confirmed that PAX is a 
reversible non-selective general BK channel pore blocker [64]. When the BK channel was found 
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to be more widely expressed throughout the central nervous system, experiments began to test its 
effectiveness in hippocampal slice work [67]. That led to the discovery that blocking the BK 
channel in hippocampal slices with PAX could have significant effects on the synaptic 
transmission of neurons by regulating action potential [67, 68] and neurotransmitter release [37, 
38]. 
 PAX has been tested in vivo as a potential therapeutic treatment for neural hyperexcitability 
exhibited during epilepsy and paroxysmal dyskinesia [57, 69]. Sheehan et al. found that in a mouse 
model, systemic injection of PAX eliminated the effects of tonic-clonic or epileptic seizures [69]. 
PAX has also been used to investigate how BK channels contributed to auditory function [70], 
specifically those channels located in the sensory cells of the cochlea, inner hair cells [71]. The 
BK channels were found to contribute to the shaping of receptor potentials [72] in these inner hair 
cells, and blocking the BK channel with PAX had no effect on apical K+ currents within the cochlea 
[73]. In animals given intracranial injections of PAX, there was significantly slower learning in 
association with pre-pulse inhibition and other training methods using auditory stimuli [74]. Due 
to the research demonstrating that PAX can alter both the effects of neurological disorders and 
auditory responses, we designed our study to characterize the specific alterations induced in 
auditory midbrain neural responses due to this treatment. We applied PAX both topically and 
systemically while recording multi-unit activity during the collection of RFs and responses for the 
gap-in-noise (GIN) paradigm. Results following blockage of the BK channel function indicated 
that this channel directly affects properties of receptive fields. We also found that the BK channel 
modulates temporal processing by increasing in minimum gap detection thresholds and gap-in-
noise recovery functions following PAX treatment. 
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4.2 Materials and Methods 
 The methods summarized here are described in detail in the manuscripts found in 
appendices C, D, and E [75, 76]. 
4.2.1 Subjects 
Multi-channel recordings were taken from 9 young (< 7 months) mixed gender CBA/CaJ 
mice (longitudinal control). Animals were housed on site 3-4 per cage with litter-mates and kept 
near 25°C, on a 12/12 hour light/dark cycle with ad lib water and food pellets. All procedures were 
preapproved by the University of South Florida Committee on Animal Resources and are 
consistent with US Federal and NIH guidelines under IACUC protocol #0245R. 
4.2.2 Surgical Preparation 
Surgery and extracellular recordings were collected and analyzed in a method identical to 
a procedure used in previous studies [75, 76], appendices C, D, and E. Mice were anesthetized 
with an intraperitoneal (i.p.) injection of ketamine and xylazine (100mg/kg and 10mg/kg). 
Following anesthesia, the top of the animal’s head and neck was then shaved of fur to prevent 
contamination of the incision site. The skin was cleaned, the skull was then exposed, and a small 
brass tube was secured to the skull surface along the sagittal suture at bregma with vet bond and 
adhered with dental cement. Mice were given a recovery period of 24-48 hours before beginning 
the experimental sessions.  
4.2.3 Drug Administration 
PAX (Sigma, St. Louis, MO, USA), was diluted for topical applications to concentrations 
of 1 µM and 0.1 µM in 1% dimethyl sulfate. The dilution of PAX was applied directly to the 
exposed IC via a micro-syringe. For systemic administration (i.p) PAX was administered in a 
manner following the protocol developed by Sheehan et al. to reach a final in vivo concentration 
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of roughly 2.2µg/kg body weight [69]. This protocol resulted in 1 animal/dose /experiment. Fresh 
solutions were made prior to each experiment.  
4.2.4 Recording Procedures 
The right IC was stereotaxically located [77] and exposed via a small (<1.0 mm) 
craniotomy. Multi-unit extracellular activity was recorded using vertically oriented single shank 
silicon acute penetrating 16-channel electrodes. The IC was mapped and a location which yielded 
at least 10 active channels and was within the central portion of the topographic map was chosen 
as the recording location for the experiment. Recording sessions lasted an average of 6-8 hours, 
and if at any time a mouse showed signs of discomfort, such as excessive movement, it was 
removed from the apparatus and testing was halted. 
4.2.5 Stimulus Generation and Presentation 
RFs from all active channels were acquired in response to tone burst stimuli presented from 
0 to 80 dB SPL in 5 dB steps and from 2 to 64 kHz, for a total of 2125 frequency and intensity 
combinations that were presented pseudo-randomly to the contralateral hemifield 5 times. For each 
RF, the best frequency (BF), the minimum threshold (MT), maximum driven rate, and spontaneous 
rate were recorded. The distance between the speaker and the pinna was fixed at 22.5 cm.  
GIN signals were used to assess temporal processing and consisted of wide band noise 
bursts presented at 70 dB SPL with embedded silent gaps having durations from 1 to 96 ms, 
presented via the free-field speaker, replicated 10 times for each gap duration. Minimum gap 
detection thresholds (MGTs), PSTH response patterns, and recovery functions were analyzed prior 
to and following application of PAX (recording post-PAX continued up to 5 hours). 
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4.2.6 Spike Sorting 
Spike waveforms were processed in MATLAB® using the TDT OpenDeveloper ActiveX 
controls and passed to AutoClass C v3.3.4, an unsupervised Bayesian classification system that 
seeks a maximum posterior probability classification, developed at the NASA Ames Research 
Center [78, 79]. Once the classes had been determined in each channel of data, they were visualized 
within a custom MATLAB® program and assigned to multi-unit, single-unit, or noise classes. 
Event classes which were categorized as noise were subsequently discarded. As recorded activity 
from most channels was elicited from the spiking of two or more neurons, all recordings units in 
this paper were considered multi-unit activity [80]. Nonetheless, there was no observation of any 
consistent differences in the RFs between single units and multi-unit clusters.  
4.2.7 Data Analysis 
RFs were analyzed using a custom MATLAB® program which classified tuning using a 
method similar to that used to classify neurons in the primary AC [81]. The RFs were sorted into 
V-shaped, multi-peak, primary-like, and closed/complex by investigators that were blind to the 
age of the animal from which the recording was made. The frequency at which driven activity is 
responsive at the lowest intensity (threshold) is classified as the characteristic frequency (CF) and 
the point in the receptive field that elicits the maximally driven activity is categorized as the BF. 
A custom MATLAB® program was used to calculate the edges of each channel’s RF, and this was 
verified via visual inspection to ensure no non-driven activity was included in the calculation. The 
change in the driven response due to treatment was further examined when collecting total induced 
spike rate-level functions derived from within the boundary of each RF. This was done by 
calculating the total number of events in response to a 25 ms CF tone presented from 0 to 80 dB 
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SPL, in 5 dB steps, and examining the summed spikes per presentation at each intensity. From 
each of these RF presentations, total spike counts were calculated.  
Statistical analysis and graphs were generated using GraphPad Prism version 6.01 for 
Windows (GraphPad Software, La Jolla, CA). Most these results are presented using box plots, 
which allow for mean, median, and the distribution of the data to be denoted. A one-way ANOVA 
test and Tukey’s repeated measures analysis procedure were used to evaluate the effects of PAX 
on the RF properties of MT and mean driven rates. A two-way ANOVA and Bonferroni’s repeated 
measures test were used to evaluate divergent effects of PAX on the maximum and total evoked 
spikes counts, while a Chi-squared test was performed to evaluate whether the frequencies of the 
RF types differed from the proportion of frequencies that would be expected by chance. Alpha was 
set at 0.05 for all statistical tests.  
4.3 Results 
 RFs were obtained from multi-unit activity prior to and following application of 1 µM (58 
units) or 0.1 µM (64 units) PAX. For each recorded unit, a full RF was collected and further 
classified according to its characteristic shape based on accepted classifications. Figure 1 shows a 
representative RF which was recorded during an IC penetration, with the boundaries of the 
excitatory region marked by the dashed white line. The MT was determined as the minimum sound 
level intensity in which a pure tone evoked a neural response. The maximum spike rate was 
calculated as the largest number of spiking events that were recorded in response to a pure tone 
stimulus, and this point was then utilized to determine the BF. 
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Figure 1. Representative example of an auditory evoked excitatory RF from an IC neuron 
before blocking the BK channel. Firing activity (as count) is plotted as a function of frequency 
vs intensity. The color map represents the response strength in spikes/presentation or repetition. 
Bandwidth was measured using the Q factor at 10, 20, 30, and 40 dB above MT. This is considered 
a V-type RF, which accounts for the majority of RFs in the IC. 
 
Figure 2 shows representative examples of four different RFs during the initial baseline 
(control) recordings in the far-left panels, and changes in the RFs following topical treatment with 
1 µM PAX, taken at one hour time points, as shown in the panels to the right. While there were 
overall observed response differences between individual neurons, they fell into 2-3 main response 
types. As shown in Figure 2a, some units completely lost responsiveness to the auditory stimuli 
and dissipated into random spontaneous activity, i.e., a complete lack of an evoked response. The 
majority of other units followed the examples shown in Figures 2b and c, where the response edges 
Threshold 
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didn’t completely disappear, though the MTs significantly increased and the overall driven rates 
significantly decreased. Figure 2a shows the loss of selectivity, 2b shows a decrease in both MT 
and driven rate, and 2c displays a decrease in sharpness of tuning of the RF. 
 
Figure 2. Representative examples of RFs collected prior to and for 5-hours following PAX 
administration. Initial control conditions are shown in the far-left panels, these are followed by 
RFs taken every hour up to 5 hours post-application application of PAX. Note that the RFs are not 
scaled to the same maximum spike rates. Although there were differences between the RFs of 
individual neurons, for all administration methods and dosage experiments (a, b, & c) the MT 
increased. Panel (a) shows a loss of selectivity, (b) shows a decrease in both MT and driven rate, 
and (c) displays a decrease in sharpness 
 
4.3.1 Paxilline Increases the RF Minimum Threshold 
The overall effect of topical PAX application on MTs is shown in Figure 3. There were 
significant differences in mean minimum thresholds between PAX treated and baseline control 
units for both topical application concentrations, with treated units exhibiting a statistically higher 
(worse) MT. Immediate threshold increases of 21 dB [F (25, 632) = 27.39, p < 0.0001] and 19.5 
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dB [F (27, 840) = 41.88, p < 0.0001] occurred within an hour of the 1 µM and 0.1 µM PAX 
application, respectively, and were maintained for at least six hours. 
 
Figure 3. The change in minimum thresholds following application of PAX. Box plots show 
the mean (denoted by the cross), and median (solid line). Blocking BK channels caused an 
immediate increase in minimum thresholds at the BF. There was a significant increase in threshold 
from baseline (blue) following topical application to the IC of both 1 µM PAX (ANOVA: 
F=27.39), p<0.0001), shown on the left, and 0.1 µM PAX (ANOVA: F=41.88), p<0.0001), shown 
on the right. At 1 µM the mean threshold increase was ~40 dB and for 0. 1 µM the effect decreased 
to ~20 dB. 
 
4.3.2 Paxilline Decreases the Maximum Driven Activity Rate 
Application of PAX resulted in a near-immediate decline in a neuron’s maximum driven 
rate to tonal stimulation, measured at the BF, of 97% and 94% respectively and produced stable 
BF shifts towards lower frequencies for over 6 hours, regardless of the PAX concentration. As 
shown in Figure 4, the application of 1 μM PAX significantly decreased the mean evoked spike 
rates by 2.3 spikes/stimuli [F (12, 422) = 27.79, p < 0.0001], from a control rate of 2.6 
spikes/stimuli. The 0.1 μM concentration also resulted in dramatic decreases, from 2.4 to 2.1 
spikes/stimuli [F (13, 443) = 17.11, p < 0.0001]. 
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Figure 4. The change in maximum driven rate following topical application of PAX. The 
maximum firing rates over a 25 ms duration were taken at the BFs, driven rates were significantly 
reduced up to 6 hours following application of both 1 µM (N = 58, ANOVA: F = 27.79, p<0.0001) 
(left) and 0.1 µM (N = 64, ANOVA: F = 17.11, p<0.0001) (right) PAX to the IC. 
 
Following systemic administration of PAX, there was a significant decrease in driven rate 
from 2.6 to approximately 1.7 spikes/stimuli [F (6, 105) = 3.451, p < 0.0038], shown in Figure 5. 
The mean evoked spike rates significantly decreased in a time-dependent fashion, in the range of 
0.6 to 1.1 spikes/stimuli, with an overall mean decrease rate of 0.9 spikes/stimuli. This observed 
decrease is approximately half of the decline in driven rate following the topical application 
discussed above and is likely due to the dosing which was selected based on previous work 
showing that a systemic dose of 4.4 ng/kg PAX significantly reduced the intensity and duration of 
seizures induced via pentylenetetrazole injection [69]. 
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Figure 5. The change in maximum driven rate following systemic administration of PAX. 
The maximum firing rates collected from the RF at BF over a 25 ms window are plotted as a 
function of time following system administration of PAX. These rates were significantly reduced 
up to 6 hours following systemic administration of 4.4 nG (N = 16, ANOVA: F = 3.451, p<0.0038) 
PAX.  
 
4.3.3 Representative Peri-stimulus Time Histograms (PSTHs) 
 PSTHs are used to classify the temporal response patterns to steady state stimuli of auditory 
system neurons into phasic or tonic categories [18]. PSTHs were classified from responses elicited 
by the GIN paradigm, where noise bursts are used to generate the activity. The GIN stimuli also 
included silent gaps of various duration in noise (see Methods). Classifications were based on the 
temporal discharge pattern in response to both noise bursts (NB1 & NB2), and divided into the 9 
categories described by Blackburn et al. and Le Beau et al. [82, 83]. These classes involve two 
general categories: phasic units which discharge at either the stimulus onset or offset and rapidly 
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cease discharging, or tonic units which discharge continuously [18]. Onset units indicate firing 
only at the onset of the noise burst, and are further divided into three categories depending on the 
duration of the response. Onset units which respond to the onset of the noise burst and followed 
by a termination in response made up 21.3% of units. On-fast (22.8% of units) and on-slow 
(17.3%) units had a similar initial clear response to the noise burst, but unlike the onset unit, were 
followed by a longer response before discharge ended. Primary-like units have a robust discharge 
to the onset of the noise burst and then gradually lower to a steady response, and made up 21.3% 
of responses. Sustained units (6.3%) discharge throughout the noise burst, and on-pause (5.5%) 
units have a clearly defined onset to the noise burst followed by a cessation in discharge, then a 
return in unit discharge. On-off units exhibit a clear response to the onset and termination of the 
noise bursts and made up approximately 2.3% of the total response types observed. Examples of 
the most common PSTH response types are shown in figure 6, along with the overall distribution 
of all classification types derived from the cumulative PSTHs for all gap durations. 
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Figure 6. PSTH classification types. Classification was based on the temporal discharge pattern 
in response to both noise bursts (NB1 & NB2). The y-axis contains the total spike count, combined 
from each repetition of the stimuli containing a unique gap length. The x-axis shows the time from 
the onset of the first noise burst to the offset of the second noise burst. The PSTHs included several 
phasic types: the onset type, which displayed only a transient response to the signal onset; on-slow 
and on-fast, similar to the on type but displaying a low-level response throughout the duration of 
the stimulus; and on–off, which discharges to both the onset and offset of the signal. The tonic 
response types were the primary-like, which displays a fast-adapting evoked response at the 
stimulus onset, followed by a strong sustained component, and the sustained, which is similar to 
the primary-like but does not show a prominent initial phasic response. Representative response 
types are shown here, along with the overall distribution of classifications derived from the 
cumulative PSTHs for all gap durations in the top right panel. 
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4.3.4 Paxilline Alters Temporal Response Patterns (PSTHs) 
The data illustrated in Figure 7 shows the overall reduction in cumulative sustained firing 
observed across all PSTH response patterns types, elicited by noise burst stimuli at one-hour time 
points following the application of PAX. The cumulative PSTHs were computed by combining 
the unique responses from each of the 10 replications at all gap durations. The reduction in 
sustained firing was also accompanied by a decrease in the total driven rates. The red line denotes 
initial pre-application firing activity, with post-PAX application represented by colored overlays. 
The largest decrease in driven activity was observed for units which exhibited the sustained firing 
activity during the entire noise burst (NB), like those of the primary-like, sustained, and on-slow 
units. Onset or phasic units with rapid decreases in spiking following NB onsets demonstrated a 
smaller post-PAX reduction in sound evoked driven rate when compared to units with sustained 
responses, a finding that is also evident in the recovery functions which will be explored later in 
the chapter. 
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Figure 7. Effects of PAX on cumulative gap PSTHs over time. The red line denotes the initial 
pre-application responses, with post-PAX application responses represented by colored overlays. 
This data illustrates the reduction in the sustained firing observed for all unit types, along with the 
overall reduction in total driven spikes. The largest decreases were observed for response type 
units which exhibited sustained firing activity during the entire noise burst (NB). Units with rapid 
decreases in spiking following NB onsets demonstrated a smaller post-PAX reduction in sound 
evoked driven rate when compared to units with sustained responses, a finding that is also evident 
in the recovery functions. 
 
4.3.5 Paxilline Application Alters GIN Recovery Functions 
Blocking the BK channels with PAX systematically prolonged the recovery functions of 
multi-unit responses with on-fast and primary-like PSTH response patterns, shown in Figure 8. 
Driven rate in response to both NBs significantly dropped 90+% from baseline after 3 hours. 
However, when we normalized the recovery functions to baseline, neural coding of the silent gap 
did not show a significant deficit, as seen in figure 9. Tonic units which contained an extended or 
sustained excitatory drive, such as primary-like, on-slow, and sustained, showed deficits in 
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temporal coding which lasted the duration of the experiment, shown in figure 10. This contrasts 
with the phasic or rapidly responding units, such as those with onset or on-fast responses. 
 
Figure 8. Effects of blocking BK channels on representative multi-unit responses with on-
fast and primary-like PSTH patterns. Recovery functions are plotted as spike counts as a 
function of gap duration. Driven rates systematically declined over 3 hours for all tested units 
following application of PAX. For all PSTH response patterns, the response to both NBs dropped 
90+% from baseline after 3 hours. 
 
 
Figure 9. Effects of blocking BK channels on normalized gap recovery functions for multi-
unit responses with on-fast PSTH response patterns. Recovery is normalized to the spike count 
elicited by NB1 and plotted as a percent of the response. Despite the decline in overall driven rate 
following PAX application, temporal coding of silent gaps did not show significant reductions 
over this same time course for on-fast units. 
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Figure 10. Effects of blocking BK channels on normalized gap recovery functions for multi-
unit responses with primary-like PSTH response patterns. Recovery is normalized to the spike 
count elicited by NB1 and plotted as a percent of the response. There was an immediate reduction 
in the driven activity, consistent with all recorded unit types. This response type also exhibited a 
decrease in the temporal coding of gaps, which lasted over the course of the experiment. 
 
4.3.6 Paxilline Alters Temporal Processing 
Evoked responses to both noise bursts of the GIN paradigm were totaled, and the MGT 
was calculated as the gap duration which induced a 50% decrease in the evoked response during 
the silence, and a 50% increase at the onset of the second noise. The MGT was only counted if this 
occurred in both the gap length identified and the next two larger gap durations. Neural responses 
to the GIN stimuli exhibited an average pre-drug MGT of 6 ms. MGTs increased post-PAX, 
regardless of concentration level, and were correlated with a systematic decrease in driven activity 
to both the pre- and post-gap carrier over time, Figure 11. The mean MGT significantly increased 
from 6 ms (M = 5.928 SEM = 0.9858) to approximately 12 ms (M = 11.01 SEM = 1.962) within 
1 hour of PAX application, then reached approximately 20 ms (M = 20.16 SEM = 3.66), which 
was maintained over the course of the experiment. 
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Figure 11. Minimum gap detection thresholds (MGTs). MGTs were significantly increased at 
all time points following PAX application. (**= p<0.005, ****= p<0.0001). 
 
4.4 Conclusions 
 These results suggest an important role of BK channels in the formation and maintenance 
of receptive field properties and temporal coding in auditory midbrain neurons. Preliminary data 
indicates that expression of BK in the aged IC is down-regulated (Appendix E Brecht et al. 2017 
in preparation) and therefore may be a factor in contributing to the central auditory processing 
deficits found in aged listeners. There is evidence that the BK channel plays a key role in the 
neuron’s ability to repolarize following excitation, which allows for it to respond to subsequent 
driving stimuli. These results suggest that BK channels are involved in both the maintenance of 
auditory midbrain response thresholds, receptive field sharpness of neurons, and initiated sound-
evoked neural activity. The loss of sound-evoked driven response results in deficits in temporal 
processing as indicated by the alterations in MGTs and GIN recovery functions. Results are 
consistent with in vitro studies showing that BK channel antagonists can modulate evoked firing 
patterns. This is the first study showing that modulating BK channels alter neural coding of sound 
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processing in vivo. Further research into the role of BK in forming excitatory RFs was examined 
through targeted blocking, using custom peptides, which form and control the channel kinetics, 
and is discussed in later chapters. This will allow for the possible delivery of drugs specific to the 
BK channel.  
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Chapter 5: Neural Correlates of Central Auditory Processing can Be Improved by a BK 
Channel Targeted Peptide in the Aged Auditory System 
 
The BK channel has been implicated in high-frequency hearing loss [84, 85] resulting from 
dysfunction of receptor cells in the peripheral auditory system. This is due to the BK channel’s 
involvement in shaping sound-evoked potentials from outer hair cells within the cochlea [86]. This 
channel is thought to determine the resonance frequency of hair cells (the sensory cells of the 
cochlea), in part due to the specific number of these channels located on the cells and their kinetics 
[87]. Thus, studies of hair cell-specific deletion of the BKα subunit indicate that humans with a 
partial or complete functional loss of BK channels would suffer from ataxia (loss of voluntary 
muscle control), increased susceptibility of outer hair cells to noise trauma, and auditory 
processing disorders [88]. However, increased excitability and precision in temporal coding 
following hair cell-specific deletion of the BKα subunit has been observed [88]. It was also found 
that knockout mice demonstrated no impairment in cochlear function when tested using auditory 
brainstem responses [84]. Testing of other genetically modified mice has shown delayed 
association of auditory stimuli with an air-puff [89], delayed learning of pre-pulse inhibition, and 
declines in startle amplitudes [74]. While most research into the functional role of the BK channel 
on hearing focuses on the peripheral system, it has been shown that expression of the BK channel 
__________________ 
3 The article “Age-related central auditory processing can be improved by a BK channel targeted 
peptide” is in preparation for publication submission, and can be found in Appendix E.  
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also varies throughout central brain regions [39, 62]. My research hopes to bypass the possible 
confounds of utilizing a knockout mouse in which alternative K+ channels may be upregulated to 
compensate for the decrease in BK channels, by directly modulating the existing BK channels. 
This paper shows that not only does the modulation of the BK channel within the auditory midbrain 
affect acoustically evoked neural responses in a manner like those observed with a channel blocker, 
but it does so in a way not seen before. This study also shows that evoked responses modulated by 
the custom derived peptide, LS3, were dependent on the frequency of the test stimuli, which was 
then replicated in behavioral assays of auditory perception.  
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Chapter 6: Summary of Results and Future Works 
 
This dissertation advances our understanding of the neural correlates of ARHL by 
answering several questions related to the decline of neural function and sound-evoked response 
properties of the central auditory system, specifically within the auditory midbrain. The inferior 
colliculus was selected for this study because of the large body of current research which 
implicates it as a pivotal region of interest for the study of ARHL. Specifically, there are many 
studies demonstrating changes in the neurochemical makeup of GABAergic circuitry connections 
and expression during aging [16, 23, 41, 90-94]. There is also evidence that the BK channel is 
highly expressed within the central auditory system at the level of the inferior colliculus [39], and 
that the BK channel is at least partly responsible for the control of neurotransmitter release [38, 
52, 72, 95-98] and therefore neural activity. 
 The first chapter answers the question: Can we alter hearing in an aged animal?  
Here it was shown that increasing available GABA within the synaptic cleft via systemic 
administration of VGB reverses the age-related down-regulation of GABA can, in fact, 
improve hearing in aged animals.  
 The second chapter focused on determining if the BK channel could be directly modulated 
with a targeted peptide, LS3. Here, it was shown that LS3 modulated the BK channel for 
both in vitro and in vivo applications. Experiments conducted by our collaborator, Dr. Luisa 
Scott, on the nematode and in human cell cultures found that LS3 altered the probability 
of opening of the BK channel, where it specifically acts as a potential channel closer. 
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 The third chapter addresses the possibility of directly modulating the BK channel in the 
auditory midbrain in an in vivo mouse model via the topical and systemic application of 
PAX, a BK channel pore blocker. PAX altered acoustically evoked neural responses when 
administered both topically and systemically, by completely abolishing sound-evoked 
activity. This produced a cascade of effects that disrupted receptive fields, intensity coding, 
and the temporal coding of sound. 
 The final chapter expands on the results of the preceding chapters and addresses the 
potential therapeutic applications of modulating the BK channel. The chapter’s major 
results are that the BK channel is present in the mammalian auditory midbrain and that 
there are changes in the expressional level of this ion channel during aging. The 
experiments conducted in the murine model show that there is a significant down-
regulation of the mRNA expression levels of BK with age, and modulating its activity can 
not only alter acoustically-evoked neural responses, but can improve salience of acoustic 
stimuli as measured through behavioral responses. 
Overall, this dissertation shows that the aged auditory system can benefit from an increase 
in GABA following treatment that increases availability of GABA within the synaptic cleft, and 
that neural function can be improved. It then establishes that the BK channel is a promising 
pharmacological target for many neurological applications, and shows that it plays an important 
role in auditory processing. My research demonstrates for the first time, via pore blockage with 
PAX, that the BK channel plays a pivotal role in regulating neural response patterns and temporal 
coding. Finally, my dissertation presents evidence that a small peptide could similarly modulate 
auditory responses without the potential side effects of non-selective targeting. 
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6.1 Pharmacological Implications 
The first study uses VGB, a drug which we found significantly improved various response 
properties (minimum threshold, driven rates, and frequency selectivity among others) of aged 
animals. However, the mechanisms underlying how GABA is increased with this drug are 
functionally different from other GABA-modulating compounds. VGB was originally considered 
as a potential treatment for epilepsy [99], although it was later discovered that treatment could 
cause deficits in the peripheral visual field for over 30% of pediatric patients [100, 101]. This 
means that despite the therapeutic promise of VGB-induced improvements in the filtering of RFs, 
which lead to increased sound evoked driven rates and decreased spontaneous activity, the side-
effects associated with VGB preclude this drug from being used for human patients. Other drugs 
which increase GABA levels within the central nervous system of humans more effectively, like 
gabapentin [21], could potentially fulfill this goal. 
Similarly, modulation of the BK channel may ultimately be a target for a therapeutic 
treatment for ARHL. However, most highly selective channel modulators such as 
tetraethylammonium, PAX, iberiotoxin, penitrem A, and charybdotoxin, are neurotoxin deviants 
taken from potent toxins and venoms [102]. Most of these toxins have complex structural makeups 
and are hence not suitable for synthesis on a large-scale basis, and will likely have a diminished 
ability to cross the BBB [76]. Due to the complex structures inhibiting transport across the BBB, 
many BK channel-targeting peptides require a lethal dose of administration to be effective [103].  
Peptides are already the normal communication messengers within the nervous system and 
comprise hormones, ligands, neurotransmitters, and other compounds. This makes them ideal for 
functioning as a novel modulator of the auditory system. Custom peptide drugs have the same 
potential for high affinity and specific binding to ion channel targets as seen with many 
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neurotoxins, though with a likely increased ability to cross the BBB because of their similarity to 
current messengers [76]. Custom designed peptides also have the potential to be highly specific to 
select isoforms of ion channels, unlike most toxins, which are non-selective for all variants [102, 
103]. This specificity becomes necessary for targeted BK channel treatments without affecting 
alternative systems [104], because of the large number of transcription variants [97, 102] and the 
differences in expression levels throughout the brain [39].    
6.2 Study Limitations 
 Elucidating the causal point of the effects comes with some difficulty due to the different 
methods we used to administer the peptide, local versus systemic. It is surprising that both types 
of administration produced similar main effects, albeit at different dosages. This finding 
overcomes one of the major hurdles in central nervous system drug development, crossing the 
BBB [105]. Another major obstacle in treatment of central nervous system disorders is specific 
targeting for intervention and packaging of these targeted drugs. In order for a molecule to pass 
the BBB, it must be small, less than 400-500 Da, and have a high lipid solubility [105]. However, 
simply being a small molecule does not guarantee the molecule will cross the BBB, and most 
packaging systems, including elastin-like polypeptides and hydrogels which protect the treatment 
molecules from phagocytic activity [106] can also increase the molecular weight, thus preventing 
them from crossing the BBB. While some of these methods show promise by accumulating in cell 
bodies [107], this does not ensure that the molecule can pass the BBB as size and specific uptake 
mechanisms become the limiting factors [105, 108]. Other high-affinity compounds such as 
nanoemulsions and polymeric nanoparticles could potentially carry peptides, however, because 
their size can vary with the payload it does not ensure successful BBB transfer [108, 109]. To 
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improve treatment options, many of these methods could be studied and potentially used to 
package the peptide and provide for local, targeted delivery.  
There is also the possibility that caudal brainstem centers might have contributed to our 
results. In order to rule this out, we analyzed P1 and P4 amplitudes from the auditory brainstem 
response following systemic administration of both PAX and our neuromodulating peptide, LS3 
(Appendix E: Brecht et al. 2017 in preparation). There were no changes in excitatory drive from 
the auditory nerve or lateral lemniscus, as measured with input/output amplitude functions. This 
is most likely tied to the low expression levels of the BK channel isoforms found within the 
auditory nuclei of the brainstem [39]. Studies of the cochlea have also found that there is little to 
no BK channel current or immunoreactivity in the low-frequency regions, but it is highly expressed 
in the high frequencies [73]. However, there were changes in electrophysiological responses from 
the auditory midbrain, which is the first location of the central auditory system to show high 
expression of the BK channel [39]. While it is not possible to say that there is no effect from 
alterations in signal processing or output in caudal nuclei, the fact that the auditory brainstem 
responses were not altered makes this conclusion more likely. However, because there are also 
high expression levels of the BK channel within the thalamus and cortex [39], effects from these 
regions are harder to rule out. Similarly, recording from the IC typically results in responses 
classified as multi-unit, which means these responses can be made up of activity from several 
different cellular types [110]. To determine the exact location of modulation and cellular responses 
in the future, patch-clamp recordings from brain slices could be used to indicate the exact cell type 
and its associated response.  
 Patch-clamp recordings would also be beneficial in illuminating where the BK channels 
are present on the responding cell. The BK channel can be found on both pre- and post-synaptic 
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nerve terminals of neurons, and thusly exerts control over the excitatory–inhibitory balance of 
neural responses [72, 97]. These variations in terminal locations may be a factor in the tonotopic 
variations observed following LS3 application (Appendix E, Brecht et. al 2017, in preparation). 
To eliminate any time-dependent diffusion effects and to better localize treatment to specific cell 
types and layer locations within the auditory midbrain, future studies should consider additional 
delivery methods such as micropumps or iontophoretic delivery systems. These delivery methods 
could also clarify if there are any recruitment or facilitatory effects associated with selectively 
modulating specific frequency regions, as specific layers can be targeted for drug delivery. 
 While the most exciting and novel findings from this research culminate in the ability to 
increase low-frequency responses of the auditory midbrain, this region is not that which is most 
commonly associated with ARHL. However, declines in responses from low-frequency hearing 
region do occur and likely contribute to complex sound processing deficits observed in the aged 
listener. While these declines are typically not as severe, they can be more detrimental to tasks 
such as picking out specific voices in a noisy environment than losses associated with high-
frequency regions. Even though the amount of benefit associated with the low-frequency gains 
could be significantly debated, a small improvement in responses properties, especially audibility, 
is considerably better than no improvement. These small improvements may also be a mechanism 
in the threshold improvements observed following LS3 application. Within the IC, neurons within 
specific layers fire in response to their CF, and neurons with similar CF may fire in synchrony, 
resulting in increases of the overall driven rates and improvements in the structure of the receptive 
field response [111, 112]. Again, future studies utilizing direct regional application and patch-
clamp studies of specific neural types would be beneficial in identifying the exact modes of 
alteration observed within this research.  
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Appendix A: Abbreviations 
 
Inferior Colliculus IC 
Receptive Field RF 
Paxilline PAX 
Peri-stimulus time histogram PSTH 
Age-related hearing loss ARHL 
γ-Aminobutyric acid GABA 
Gap-in-noise GIN 
Minimum Gap Detection Threshold MGT 
Minimum Threshold MT 
Characteristic Frequency CF 
Best Frequency BF 
Noise Burst NB 
First Noise Burst NB1 
Second Noise Burst NB2 
Vigabatrin VGB 
Blood-Brain Barrier BBB 
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Fields and Intensity Coding of Auditory Midbrain Neurons in Mice 
 
Appendix C contains the manuscript titled, “Increasing GABA reverses age-related 
declines in excitatory receptive fields and intensity coding of auditory midbrain neurons in mice”, 
which is under a second review by Neurobiology of Aging. 
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the Mouse Inferior Colliculus 
 
Appendix D contains the manuscript titled, “A novel BK channel-targeted peptide 
suppresses sound evoked activity in the mouse inferior colliculus”, published by Nature: Scientific 
Reports. 
  
76 
  
77 
  
78 
  
79 
 
80 
 
81 
 
82 
 
83 
 
84 
 
85 
 
86 
 
87 
 
88 
 
 89 
Appendix E: Neural Correlates of Central Auditory Processing can Be Improved by a BK 
Channel Targeted Peptide in the Aged Auditory System 
 
Appendix E contains the manuscript titled, “Age-related central auditory processing can 
be improved by a BK channel targeted peptide”, which is in preparation for submission. 
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